Impel Snags $750K Grant

Xconomy Seattle — 

Seattle-based Impel Neurpharma, the developer of technology to deliver drugs to the brain, said today it has secured a two-year, $750,000 grant from the U.S. Department of Defense. The company, a University of Washington spinout, previously got a $500,000 grant from the National Institutes of Health to support its method for delivering drugs through the upper nasal cavity, bypassing the blood-brain barrier, which limits the effectiveness of many neurological drugs. For more on Impel and its technology, check this profile from August 2008, when the company was getting going.